Commercially Available Nanoparticles for Cancer Treatment

Published on 18 Dec, 2015

Since their advent in the late 1960s, several nanoparticle-based drugs are being clinically used in innovative therapeutic approaches with notable success.

Several nano formulations of liposomal and PEG-conjugated liposomal, polymeric micelles anticancer drugs have been approved, with some already approved for clinical use and others undergoing phase II and III clinical trials.

Commercially Available Nanoparticle-based Cancer Treatment

For more information about the use of Nanoparticles and their applications in cancer treatment, check out our report on Nanoparticle Drug Delivery Systems for Cancer Treatment.

nanoparticles cancer treatment